Record Q2 at CME

Chairman Terry Duffy said a contributor to this growth has been a continuing shift in the global derivatives landscape "as users are increasingly focused on credit quality and cognisant of the appeal of transparent, exchange-traded instruments with central counterparty clearing."

CME’s net revenues increased 32% to $142 million for Q2 this year, compared with $108 million for the same period in 2002. Average daily volume increased 23% year-on-year to nearly 2.7 million contracts for Q2 2003.


Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact customer services -, or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to FX Markets? View our subscription options

If you already have an account, please sign in here.

You need to sign in to use this feature. If you don’t have a FX Markets account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: